Benzquinamide

Source: Wikipedia, the free encyclopedia.
Benzquinamide
Clinical data
Trade namesPromecon, Quantril, Emete-Con
License data
Routes of
administration
Suppository, injection
ATC code
  • none
Legal status
Legal status
Identifiers
  • 3-(Diethylcarbamoyl)-9,10-dimethoxy-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-yl acetate
JSmol)
  • CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(=O)C
  • InChI=InChI=1S/C22H32N2O5/c1-6-23(7-2)22(26)17-13-24-9-8-15-10-20(27-4)21(28-5)11-16(15)18(24)12-19(17)29-14(3)25/h10-11,17-19H,6-9,12-13H2,1-5H3 ☒N
  • Key:JSZILQVIPPROJI-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Benzquinamide is a discontinued

post-operative care. It was first synthesised by Pfizer in the 1960s.[2]
[3]

References

  1. ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. PMID 13992595
    .
  3. .